Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia

Abstract

BackgroundThe clinical course of chronic lymphocytic leukemia (CLL) is highly variable; some patients follow an indolent course, but others progress to a more advanced stage. The mutational status of rearranged immunoglobulin heavy chain variable (IGVH) genes in CLL is a feature that is widely recognized for dividing patients into groups that are related to their prognoses. However, the regulatory programs associated with the IGVH statuses are poorly understood, and markers that can precisely predict survival outcomes have yet to be identified.MethodsIn this study, (i) we reconstructed gene regulatory networks in CLL by applying an information-theoretic approach to the expression profiles of 5 cohorts. (ii) We applied master regulator analysis (MRA) to these networks to identify transcription factors (TFs) that regulate an IGVH mutational status signature. The IGVH mutational status signature was developed by searching for differentially expressed genes between the IGVH mutational statuses in numerous CLL cohorts. (iii) To evaluate the biological implication of the inferred regulators, prognostic values were determined using time to treatment (TTT) and overall survival (OS) in two different cohorts.ResultsA robust IGVH expression signature was obtained, and various TFs emerged as regulators of the signature in most of the reconstructed networks. The TF targets expression profiles exhibited significant differences with respect to survival, which allowed the definition of a reduced profile with a high value for OS. TCF7 and its targets stood out for their roles in progression.ConclusionTFs and their targets, which were obtained merely from inferred regulatory associations, have prognostic implications and reflect a regulatory context for prognosis.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-2189-6) contains supplementary material, which is available to authorized users.

Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks

“…Moreover, the described method for ATAC-seq-based inference of gene regulatory networks ( Fig. 5 ) establishes a data-driven approach for dissecting regulatory cell states—including their differences between disease subtypes—that is highly complementary to previous work aimed at inferring regulatory networks from transcriptome data 46 47 48 . Finally, the ‘chromatin accessibility corridor’ ( Fig.…”

Multi-regional Neurodegeneration in Alzheimer’s disease: Meta-analysis and data integration of transcriptomics data

“…ARACNe network of each brain region was constructed based on the dataset with the best score in the MetaQC analysis. Mutual information(MI) threshold and Data Processing Inequality (DPI) tolerance set to 0.05 and 0%, respectively [35].…”

Dissecting CLL through high-dimensional single-cell technologies

“…Advances in bulk genomics have defined the spectrum of mutations and genomic changes within CLL and are undergoing evaluation for impact on prognosis and prediction of outcomes in CLL, 11,72,[113][114][115] as well as incorporation of newer epigenetic and transcriptional insights. [116][117][118][119] Single-cell level information can provide valuable insights for CLL patients at diverse points in their disease course (Figure 4). At diagnosis, when leukemia cells are in abundance, single-cell analytics will enable a detailed snapshot of the precise composition of the leukemia and also an assessment of the accessory immune cells.…”